Batavia Bioservices, headquarted in Leiden, The Netherlands, will launch a U.S. lab facility in Woburn, MA. Batavia provides DNA cloning to Phase I/II manufacturing for all major classes of biopharmaceuticals, including antibodies, proteins and vaccines.   The 5,500-sq.-ft. facility contains multiple BSL-2 labs dedicated to molecular biology, mammalian cell line generation, protein production and purification, and assay development. The company has hired six employees for the new facility, with ...